학술논문
Randomized controlled trial of molnupiravir SARS-CoV-2 viral and antibody response in at-risk adult outpatients
Document Type
Article
Author
Standing, J.F.; Buggiotti, L.; Guerra-Assuncao, J.A.; Woodall, M.; Ellis, S.; Agyeman, A.A.; Okechukwu, M.; Kirkpatrick, E.; Jacobs, A.I.; Smith, C.M.; Breuer, J.; Burns, D.; Thalasselis, C.; Tomlinson, M.; Miller, C.; Brown, J.; Hatcher, J.; Yongblah, F.; Williams, C.A.; Roy, S.; Martin-Bernal, L.M.; Williams, R.; Bayzid, N.; Sanderson, T.; Ashford, F.B.; Emmanuel, B.; Afzal, Z.M.; Shields, A.; Richter, A.G.; Dorward, J.; Gbinigie, O.; Van Hecke, O.; Yu, L.-M.; Hayward, G.; Hobbs, F.D.R.; Butler, C.; Lown, M.; Francis, N.; Little, P.; Jani, B.; Richards, D.B.; Rahman, N.M.; Thomas, N.P.B.; Hart, N.D.; Evans, P.; Andersson, M.; Hood, K.; Nguyen-Van-Tam, J.S.; Khoo, S.; Lowe, D.M.; Allen, J.; Hadley, E.; McHugh, T.
Source
In: Nature Communications . (Nature Communications, December 2024, 15(1))
Subject
Language
English
ISSN
20411723